Brief: Atara Biotherapeutics Announces First Quarter 2023 Financial Results

Atara Biotherapeutics

08/05/2023 22:29

May 8 (Reuters) - Atara Biotherapeutics Inc  ATRA.O :
    * ATARA BIOTHERAPEUTICS ANNOUNCES FIRST QUARTER 2023
FINANCIAL
RESULTS AND OPERATIONAL PROGRESS
    * ATA3219 IND FILING ANTICIPATED END OF Q2 2023
    * ATA188 PHASE 2 EMBOLD STUDY PRIMARY DATA READOUT ON-TRACK
FOR
OCTOBER 2023
    * QTRLY LOSS PER SHARE $0.72
    * Q1 EARNINGS PER SHARE VIEW $-0.39 -- REFINITIV IBES DATA
    * ATARA BIOTHERAPEUTICS -CASH, CASH EQUIVALENTS & SHORT-TERM
INVESTMENTS AS OF MARCH 31, 2023, TOTALED $205.4 MILLION VERSUS
$242.8 MILLION AS OF DECEMBER 31, 2022
    * BELIEVES CASH AND INVESTMENTS AS OF MARCH 31, 2023, WILL
BE
SUFFICIENT TO FUND CO'S PLANNED OPERATIONS INTO Q2 2024

Source text for Eikon:  ID:nBw6nhlXya 
Further company coverage:  ATRA.O 

 ((Reutersbriefs@thomsonreuters.com;))